Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
12/2010
12/08/2010EP2258725A2 Cytokine receptor zcytor17
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258718A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/08/2010EP2257569A1 Method of treatment using antimicrobial composition
12/08/2010EP1994943B1 Chimeric vaccine antigens against classical swine fever virus
12/08/2010EP1427750B1 Modified transferrin fusion proteins
12/08/2010EP1392717B1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
12/08/2010CN101910402A N-terminal XA27 signal anchor and its use for localization of fusion proteins
12/08/2010CN101906413A Heterologous expression of neisserial proteins
12/08/2010CN101906166A Streptococcus recombination subunit vaccine and preparation method
12/08/2010CN101906165A Expression product in series of two fish antibacterial peptide genes and expression method thereof
12/08/2010CN101906164A Coupled protein
12/08/2010CN101906163A Immunocontraceptive synthetic peptide and immunocontraceptive chimeric peptide and application thereof
12/08/2010CN101906161A Anti-human coagulation factor VII monoclonal antibody, preparation method thereof and use thereof
12/08/2010CN101906160A Human blood coagulation factor VIII resisting monoclonal antibody as well as preparation method and application thereof
12/08/2010CN101293099B Polypeptide vaccine for resisting multiple hypotype avian influenza viruses and preparation method thereof
12/08/2010CN101165070B A series of fusion protein with dual biological activity and medical treatment thereof
12/07/2010US7847080 Expression vector comprising nucleotide sequences coding novel g-protein coupled receptors for identifying modulators of sweet taste transduction
12/07/2010US7847079 Albumin fusion proteins
12/07/2010US7846453 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3
12/07/2010CA2256543C Methods and compositions useful for inhibition of angiogenesis
12/02/2010WO2010137717A1 Method for highly sensitive detection of protein-protein interaction
12/02/2010WO2010137019A1 Photocatalytic hydrogen production in cyanobacteria
12/02/2010WO2010137012A1 Peptide therapy for amphiregulin mediated diseases
12/02/2010WO2010136480A1 Antigen-binding proteins
12/02/2010WO2010115278A8 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
12/02/2010WO2010115207A9 Chimeras between gpc-receptors and binding partners thereof
12/02/2010WO2010097709A3 Polypeptides for the prevention or treatment of malaria
12/02/2010US20100305194 Modified and stabilized gdf propeptides and uses thereof
12/02/2010US20100305040 Production of soluble recombinant protein by pi value control of n-terminal
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303815 METHOD OF TREATING ANEMIA BY ADMINISTERING IL 1ra
12/02/2010CA2763439A1 Antigen-binding proteins
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2256135A1 Proteolytically cleavable fusion protein comprising a blood coagulation factor
12/01/2010EP2256134A1 IgG Fc fragment for a drug carrier and method for the preparation thereof
12/01/2010EP2256133A1 Bioconjugation of macromolecules
12/01/2010EP1373301B1 Reducing the immunogenicity of fusion proteins
12/01/2010CN1727362B Preparation and application of vaccine for curing tumor in positive carcino-embryonic antigen
12/01/2010CN1721446B Fusion protein and method for preparing same
12/01/2010CN1646154B Albumin-fused anti-angiogenesis peptides
12/01/2010CN101903406A Bivalent, bispecific antibodies
12/01/2010CN101903405A Bivalent, bispecific antibodies
12/01/2010CN101903404A Bivalent, bispecific antibodies
12/01/2010CN101900727A Bovine tuberculosis antibody identifying and detecting test strip prepared by applying Rv3872 novel fusion protein
12/01/2010CN101899489A Method for modeling production of fusion protein by utilizing trans-splicing of intein
12/01/2010CN101899469A Shuttle plasmid and method for efficiently expressing cecropin and lysozyme genes
12/01/2010CN101899461A Fusion gene capable of encoding influenza A virus NP protein and M2e polypeptide
12/01/2010CN101899460A Method for preparing fusion protein capable of lowering food allergen reaction
12/01/2010CN101899419A Insect baculovirus expression system and method for expressing E2 protein using same
12/01/2010CN101899118A Fusion protein HABP-mKate and preparation method and application thereof
12/01/2010CN101899117A Streptavidin/interleukin 21 fusion protein
12/01/2010CN101899116A Non-invasive high-penetrability epidermal growth factor and application thereof
12/01/2010CN101323643B Optimized TACI-Fc fuse protein
12/01/2010CN101157728B ERK2 combination polypeptide and preparation thereof
11/2010
11/30/2010US7842785 G-protein coupled receptor for use in identifying modulators of taste perception in mammals; improving the palatability of low-calorie beverages
11/30/2010US7842784 Antagonizing bone morphogenetic protein activity; utilizing polypeptide comprising amino acids 22-452 of sequence 8; bone diseases, tissue regeneration, wound healing
11/30/2010US7842503 Hybrid recombinases for genome manipulation
11/25/2010WO2010134666A1 Dual targeting antibody of novel form, and use thereof
11/25/2010WO2010134642A1 Protein complex that catalyses asymmetric oxidation and method for preparing same
11/25/2010WO2010134305A1 Peptidic antigen that induces antibody recognizing three-dimensional structure of hiv and method for synthesizing same
11/25/2010WO2010134226A1 Establishment of motif comprising acidic amino acid, capable of stabilizing protein in cells, and applicable to protein therapy, control of differentiation/undifferentiation of cell and antibody therapy
11/25/2010WO2010103342A3 Hybrid vegetable protein and method for obtaining same
11/25/2010WO2010083225A3 Targeted cryptosporidium biocides
11/25/2010WO2010082804A3 Method for producing physiologically active protein or peptide using immunoglobulin fragment
11/25/2010WO2010081095A3 Methods and compositions for inhibiting hepatitis c virus replication
11/25/2010WO2010056808A3 Compositions and methods for re-programming and re-differentiating cells
11/25/2010US20100298236 Soluble gp130 muteins with improved binding activity
11/25/2010US20100298229 Osteoprotegerin
11/25/2010US20100297695 Nucleic Acids Encoding Chimeric CD154 Polypeptides
11/25/2010US20100297658 Detecting methylated mammalian nucleic acid in stool
11/25/2010US20100297219 Methods and Compositions for Modifying Apolipoprotein B mRNA Editing
11/25/2010US20100297060 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
11/25/2010CA2762555A1 Dual targeting antibody of novel form, and use thereof
11/24/2010EP2252634A1 Hybrid polypeptides comprising gbs-80 and spb1 proteins of streptococcus
11/24/2010EP2252632A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof
11/24/2010EP1926753B1 Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate-binding module as second amino acid sequence
11/24/2010EP1355919B1 Molecules with extended half-lives, compositions and uses thereof
11/24/2010EP0804572B1 Fusion protein comprising bpTK7
11/24/2010CN1826527B Methods for protein labeling based on acyl carrier protein
11/24/2010CN101896504A Bivalent, bispecific antibodies
11/24/2010CN101891826A Targeted hIL-10 recombinant protein and application thereof
11/24/2010CN101891825A Recombinant fusion proteins of hepatitis B core proteins and tuberculosis antigen or antigen fragments and application thereof
11/24/2010CN101891824A Vascular targeting soluble fusion protein TrxHis-hDlll-RGD
11/24/2010CN101891823A Exendin-4 and analog fusion protein thereof
11/24/2010CN101891822A Fusion polypeptide use for preventing and treating senile dementia by brain barrier permeability
11/24/2010CN101891821A T1R hetero-oligomeric taste receptor, and cell line expressing the receptor, and use thereof for identification of tasty compound
11/24/2010CN101891815A CK19 monoclonal antibody, and preparation method and application thereof
11/24/2010CN101891814A Anti-osteopontin OPN monoclonal antibody and application thereof
11/23/2010US7838635 CD16A binding proteins and use for the treatment of immune disorders
11/23/2010US7838274 polynucleotides encoding the phospholipases; using these enzymes in industrial processes and methods of diagnosing fungal infections; Aspergillus niger; recombinant host cells wherein the expression of a phospholipase is significantly increased or wherein the activity of the phospholipase is increased
11/23/2010US7838266 A purified pro-cytolytic peptide; used to treat localized and metastatic prostate cancer; administered intratumorally and/or intraprostatically
11/23/2010US7838248 anti-IL-18 Receptor accessory protein antibody; used in the study of cell signaling in response to IL-18 stimulation, and inducible protein expression systems based on the involvement of ACPL polypeptides in cell signaling
11/23/2010CA2295189C Type-1 ribosome-inactivating protein
11/23/2010CA2209301C Redirection of cellular immunity by protein-tyrosine kinase chimeras
11/18/2010WO2010132092A2 Cytidine deaminase fusions and related methods
11/18/2010WO2010057032A3 Self-assembly of protein-based biomaterials with multiple morphologies
11/18/2010US20100292151 Use of human cytokine receptor
11/17/2010EP2251357A1 Camelidae single domain antibodies VHH directed against epidermal growth factor receptor and uses therefor
11/17/2010EP2250196A2 Engineered antibody constant domain molecules
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 295